GB0226723D0 - Antibodies for in vitro use - Google Patents
Antibodies for in vitro useInfo
- Publication number
- GB0226723D0 GB0226723D0 GB0226723A GB0226723A GB0226723D0 GB 0226723 D0 GB0226723 D0 GB 0226723D0 GB 0226723 A GB0226723 A GB 0226723A GB 0226723 A GB0226723 A GB 0226723A GB 0226723 D0 GB0226723 D0 GB 0226723D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibodies
- vitro use
- vitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226723A GB0226723D0 (en) | 2002-11-15 | 2002-11-15 | Antibodies for in vitro use |
AU2003219277A AU2003219277A1 (en) | 2002-03-14 | 2003-03-14 | Intracellular antibodies |
PCT/GB2003/001077 WO2003077945A1 (en) | 2002-03-14 | 2003-03-14 | Intracellular antibodies |
AU2003282241A AU2003282241A1 (en) | 2002-11-15 | 2003-11-14 | Antibodies for in vitro use |
PCT/GB2003/004953 WO2004046188A2 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
JP2004570301A JP2006521088A (en) | 2002-11-15 | 2003-11-14 | Anti-activated RAS antibody |
AU2003282247A AU2003282247A1 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
EP03773865A EP1565495A2 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
PCT/GB2003/004944 WO2004046187A2 (en) | 2002-11-15 | 2003-11-14 | Antibodies for in vitro use |
CA002506128A CA2506128A1 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
US11/127,903 US20050288492A1 (en) | 2002-11-15 | 2005-05-12 | Anti-activated RAS antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226723A GB0226723D0 (en) | 2002-11-15 | 2002-11-15 | Antibodies for in vitro use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0226723D0 true GB0226723D0 (en) | 2002-12-24 |
Family
ID=9947929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0226723A Ceased GB0226723D0 (en) | 2002-03-14 | 2002-11-15 | Antibodies for in vitro use |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003282241A1 (en) |
GB (1) | GB0226723D0 (en) |
WO (1) | WO2004046187A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2911514A1 (en) | 2013-05-06 | 2014-11-13 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
PL3218005T3 (en) | 2014-11-12 | 2023-05-02 | Seagen Inc. | Glycan-interacting compounds and methods of use |
US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
IL302822A (en) | 2015-11-12 | 2023-07-01 | Seagen Inc | Glycan-interacting compounds and methods of use |
WO2018094143A1 (en) | 2016-11-17 | 2018-05-24 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
BR112019018043A2 (en) | 2017-03-03 | 2020-04-07 | Seattle Genetics Inc | cancer treatment method, and, antibody-drug conjugate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2344886B (en) * | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
AU2002355477B2 (en) * | 2001-08-03 | 2008-09-25 | Medical Research Council | Method of identifying a consensus sequence for intracellular antibodies |
WO2003077945A1 (en) * | 2002-03-14 | 2003-09-25 | Medical Research Council | Intracellular antibodies |
-
2002
- 2002-11-15 GB GB0226723A patent/GB0226723D0/en not_active Ceased
-
2003
- 2003-11-14 WO PCT/GB2003/004944 patent/WO2004046187A2/en not_active Application Discontinuation
- 2003-11-14 AU AU2003282241A patent/AU2003282241A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004046187A2 (en) | 2004-06-03 |
AU2003282241A8 (en) | 2004-06-15 |
AU2003282241A1 (en) | 2004-06-15 |
WO2004046187A3 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1494693A4 (en) | Cripto-specific antibodies | |
IL241315A (en) | Method for enhancing the in vitro shelf-life of purified -glucocerebrosidase | |
IL165804A0 (en) | In vitro fertilisation | |
PL375405A1 (en) | Antibodies | |
IL225633A0 (en) | Anti-alpha-v-beta - 6 antibodies and uses thereof | |
PT1599504E (en) | Modified antibody | |
IL175710A0 (en) | Anti-mpl antibody | |
EP1551447A4 (en) | Anti-addl antibodies and uses thereof | |
IL175608A0 (en) | Antibodies | |
AU2003217912A8 (en) | Antibody optimization | |
EP1572131A4 (en) | Antibody therapy | |
EP1535930A4 (en) | Antibody specific to central tetra-protein | |
AU2003239197A8 (en) | Novel stable anti-cd22 antibodies | |
EP1699485A4 (en) | Anti-hydroxylase antibodies and uses thereof | |
IL172510A0 (en) | Antibodies and uses thereof | |
IL172511A0 (en) | Specific human antibodies | |
EP1497649A4 (en) | Antibodies specific for mucin polypeptide | |
EP1589033A4 (en) | Antibody and use thereof | |
IL166063A0 (en) | Antibodies and uses thereof | |
GB0226723D0 (en) | Antibodies for in vitro use | |
AU2002953238A0 (en) | In vitro immunization | |
GB0306618D0 (en) | Antibody | |
GB0226878D0 (en) | Antibodies | |
EP1627888A4 (en) | Antibody and use thereof | |
HK1209139A1 (en) | Modified antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |